| abstract |
The present invention provides compositions for the intranasal administration of granisetron or a pharmaceutically acceptable salt thereof. Preferred compositions of the invention are in the form of an aqueous solution. Optionally, the compositions of the invention comprise chitosan, a salt or derivative thereof or a salt of a derivative of chitosan. The compositions can be used for the treatment or prevention of nausea and/or vomiting. |